Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Other neoplasm 3Breast 3Tumor-Agnostic 1Thoracic 1Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Breast Neoplasms 3Pain 1Neoplasms 1Inflammation 1Hypertension 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Sulindac × Breast × Clear all
NCT04542135 2025-06-03

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Stony Brook University

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms

NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

NCT00039520 2014-05-06

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Fox Chase Cancer Center

Phase 2 Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡